Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/6576 stock hub

TPEX/6576 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6576is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6576

In the news

Latest news · TPEX/6576

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-69.9

P25 -16.2P50 0.3P75 9.8

ROIC-35.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6576 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

TWD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 12.2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006576002
Last refreshed	2026-05-10
Market cap	TWD 12.4B
Price	TWD 79
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6576
Website	https://www.foreseepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.1%
EV Earnings	-13.81x
EV/FCF	-14.43x
EV/Sales	28.28x
FCF yield	-6.79%
P/B ratio	13.39x
P/S ratio	28.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-199.95%
EBITDA Margin	-188.32%
Gross margin	68.22%
Gross Profit	TWD 294.2M
Gross Profit Growth	22.69%
Gross Profit Growth Q	-71.16%
Gross Profit Growth3 Y	2.16%
Gross Profit Growth5 Y	11.15%
Net Income	TWD -883.2M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-198.99%
Profit Margin	-204.78%
ROA	-31.07
Roa5y	-28.47
ROCE	-84.2
ROE	-69.85
Roe5y	-64.12
ROIC	-35.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.11%
Cagr1y	18.99%
Cagr3y	-4.38%
Cagr5y	-1.8%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	3.01x
Revenue Growth Q	-62.85x
Revenue Growth Years	2x
Revenue Growth3 Y	12.67x
Revenue Growth5 Y	13.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.25
Assets	TWD 1.3B
Cash	TWD 479.5M
Current Assets	TWD 985.7M
Current Liabilities	TWD 286.3M
Debt	TWD 231.7M
Debt Equity	TWD 0.25
Debt FCF	TWD -0.27
Equity	TWD 929.6M
Interest Coverage	-154.9
Liabilities	TWD 380.8M
Long Term Assets	TWD 324.7M
Long Term Liabilities	TWD 94.5M
Net Cash	TWD 247.8M
Net Cash By Market Cap	TWD 1.99
Net Cash Growth	-77.62%
Net Debt Equity	TWD -0.27
Tangible Book Value	TWD 818.5M
Tangible Book Value Per Share	TWD 5.2
WACC	7.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.44
Inventory Turnover	0.83
Net Working Capital	TWD 431.1M
Quick ratio	1.89
Working Capital	TWD 699.4M
Working Capital Turnover	TWD 0.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1.07%
1Y total return	18.98%
200-day SMA	79.25
3Y total return	-12.58%
50-day SMA	79.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-8.69%
All Time High	141
All Time High Change	-43.97%
All Time High Date	2022-03-25
All Time Low	35.1
All Time Low Change	125.07%
All Time Low Date	2020-03-23
ATR	1.85
Beta	0.67
Beta1y	0.32
Beta2y	0.56
Ch YTD	-1.99
High	82.6
High52	93.7
High52 Date	2025-11-17
High52ch	-15.69%
Low	78.7
Low52	61.6
Low52 Date	2025-06-23
Low52ch	28.25%
Ma50ch	-0.35%
Price vs 200-day SMA	-0.31%
RSI	48.14
RSI Monthly	48.29
RSI Weekly	49.86
Sharpe ratio	0.72x
Sortino ratio	1.63
Total Return	-12.8%
Tr YTD	-1.99
Tr1m	1.41%
Tr1w	-0.63%
Tr3m	-9.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -862.3M
Operating margin	-199.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,042,164%
Net Borrowing	-64,049,000
Shares Insiders	8.51%
Shares Institutions	1.15%
Shares Out	157,537,541
Shares Qo Q	1.97%
Shares Yo Y	12.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -878.9M
Average Volume	196,611.3x
Bv Per Share	5.9
CAPEX	TWD -3M
Ch10y	-2.47
Ch1m	1.41
Ch1w	-0.63
Ch1y	18.98
Ch3m	-9.2
Ch3y	-13.57
Ch5y	-9.71
Ch6m	2.6
Change	-0.88%
Change From Open	-4.36
Close	79.7
Days Gap	3.64
Depreciation Amortization	50,126,000
Dollar Volume	16,737,967
Earnings Date	2026-05-12
EBIT	TWD -862.3M
EBITDA	TWD -812.2M
EPS	TWD -5.7
F Score	3
FCF	TWD -845.2M
FCF EV Yield	-6.93x
FCF Per Share	TWD -5.37
Financing CF	134,179,000
Fiscal Year End	December
Founded	2,013
Income Tax	TWD 24.9M
Investing CF	-161,746,000
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Ma150	79.94
Ma150ch	-1.17%
Ma20	79.09
Ma20ch	-0.11%
Net CF	-887,781,000
Next Earnings Date	2026-05-12
Open	82.6
Position In Range	7.69
Ppne	207,156,000
Price Date	2026-05-08
Ptbv Ratio	15.21
Relative Volume	1.12x
Revenue	431,274,000x
SBC By Revenue	7.81x
Share Based Comp	33,691,000
Tax By Revenue	5.78x
Tr6m	2.6%
Volume	211,873
Z Score	10.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6576 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6576 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6576?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+8.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.8%

Negative means the company is buying back shares.

Technical

TPEX/6576 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.1

Neutral momentum band

Price vs 200-day MA

-0.3%

50/200-day relationship not available

Beta (5Y)

0.67

Less volatile than the market

Sharpe ratio

0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6576

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6576 stock rating?

tpex/6576 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6576 analysis?

The full report lives at /stocks/tpex/6576/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6576?

The latest report frames tpex/6576 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6576 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.